Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

501.44
+1.090.22%
Volume:232.29K
Turnover:116.83M
Market Cap:21.51B
PE:17.94
High:505.36
Open:500.62
Low:500.15
Close:500.35
52wk High:609.35
52wk Low:397.00
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.35
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.36
PE(LYR):18.00

Loading ...

United Therapeutics CEO Martine Rothblatt Disposes of USD 3.29 Million in Common Shares

Reuters
·
Jul 14

United Therapeutics Director Jan Malcolm Sells 325 Shares for $178,941.75

Reuters
·
Jul 11

United Therapeutics is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 11

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says

MT Newswires Live
·
Jul 11

BETA Technologies Completes First FAA Evtol Integration Pilot Flights Carrying Manufactured Organs

Reuters
·
Jul 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 10

BofA Securities Adjusts United Therapeutics Price Target to $613 From $620

MT Newswires Live
·
Jul 10

United Therapeutics price target lowered to $613 from $620 at BofA

TIPRANKS
·
Jul 10

United Therapeutics CEO Martine Rothblatt Disposes of USD 5.18 Million in Common Shares

Reuters
·
Jul 09

What United Therapeutics (UTHR)'s Centralized LungFX EVLP FDA Approval Means For Shareholders

Simply Wall St.
·
Jul 08

United Therapeutics is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

United Therapeutics CEO Martine Rothblatt Sells 9,500 Common Shares for $5.21 Million

Reuters
·
Jul 07

RBC Capital Raises United Therapeutics Price Target to $704 From $701, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

United Therapeutics CEO Martine Rothblatt Disposes of 8,500 Common Shares Worth $4.63 Million

Reuters
·
Jul 03

United Therapeutics Acquires Thymmune Therapeutics for USD 140 Million Upfront

Reuters
·
Jul 02

United Therapeutics Corp - Deal Valued at $140 Mln Cash Plus up to $160 Mln in Earn-outs by 2031

THOMSON REUTERS
·
Jul 02

14 Value Stocks of Companies Primed for Rapid Growth Through 2028

Dow Jones
·
Jul 02

United Therapeutics CEO Martine Rothblatt Reports Disposal of 9,500 Common Shares Valued at $5.16 Million

Reuters
·
Jul 01

United Therapeutics IPF Opportunity Outweighs Base Business Risks, UBS Says

MT Newswires Live
·
Jul 01

United Therapeutics Shareholders Endorse 2026 Governance and Pay

TIPRANKS
·
Jun 30